SELLAS Life Sciences (SLS) Enterprise Value (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | SELLAS Life Sciences | 1.61 Bn | 1.61 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.00% |
| Dec 31, 2025 | 99.77% |
| Sep 30, 2025 | -44,220.00% |
| Jun 30, 2025 | 0.00% |
| Mar 31, 2025 | 99.28% |
| Dec 31, 2024 | -13,786.00% |
| Sep 30, 2024 | 0.00% |
| Jun 30, 2024 | 0.00% |
| Mar 31, 2024 | 96.05% |
| Dec 31, 2023 | 36.26% |
| Sep 30, 2023 | -3,869.00% |
| Jun 30, 2023 | 99.58% |
| Mar 31, 2023 | -39.57% |
| Dec 31, 2022 | -17,025.00% |
| Sep 30, 2022 | 0.00% |
| Jun 30, 2022 | 0.00% |
| Mar 31, 2022 | 99.53% |
| Dec 31, 2021 | 18.80% |
| Sep 30, 2021 | -26,200.00% |
| Jun 30, 2021 | 99.64% |
| Mar 31, 2021 | 20.68% |
| Dec 31, 2020 | -330.51% |
| Sep 30, 2020 | -148.48% |
| Jun 30, 2020 | -3,200.00% |
| Mar 31, 2020 | 0.00% |
| Dec 31, 2019 | 13.04% |
| Sep 30, 2019 | -15.00% |
| Jun 30, 2019 | 96.12% |
| Mar 31, 2019 | 51.73% |
| Dec 31, 2018 | -5,237.00% |
| Sep 30, 2018 | 98.84% |
| Jun 30, 2018 | 0.14% |
| Mar 31, 2018 | 32.45% |
| Dec 31, 2017 | 1.16% |
| Sep 30, 2017 | 5.13% |
| Jun 30, 2017 | 24.88% |
| Mar 31, 2017 | -199.32% |
| Dec 31, 2016 | 75.33% |
| Sep 30, 2016 | -25.14% |
| Jun 30, 2016 | -4,785.29% |
| Mar 31, 2016 | 71.30% |
| Dec 31, 2015 | 95.98% |
| Sep 30, 2015 | 23.34% |
| Jun 30, 2015 | 14.34% |
| Mar 31, 2015 | -123.51% |
| Dec 31, 2014 | 4.05% |
| Sep 30, 2014 | 37.06% |
| Jun 30, 2014 | 25.30% |
| Mar 31, 2014 | -9.71% |
| Dec 31, 2013 | 7.02% |
| Sep 30, 2013 | -145.69% |
| Jun 30, 2013 | -19.67% |
| Mar 31, 2013 | 46.72% |
| Dec 31, 2012 | 36.17% |
| Sep 30, 2012 | -167.30% |
| Jun 30, 2012 | -120.99% |
| Mar 31, 2012 | 81.79% |
| Dec 31, 2011 | -204.51% |
| Sep 30, 2011 | 12.49% |
| Jun 30, 2011 | -61.34% |
| Mar 31, 2011 | -61.30% |
| Dec 31, 2010 | -142.98% |
| Sep 30, 2010 | 44.32% |